Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys
•α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in MPTP-treated monkeys.•α-Syn phosphorylation is accompanied by alterations in its regulatory enzymes PP2A and PLK2.•DAergic degeneration is synchroniz...
Saved in:
Published in | Neuroscience letters Vol. 716; p. 134640 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
18.01.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in MPTP-treated monkeys.•α-Syn phosphorylation is accompanied by alterations in its regulatory enzymes PP2A and PLK2.•DAergic degeneration is synchronized in the brain and colon of MPTP-treated monkeys.•Altered PLK2 and PP2A activity contribute to α-syn phosphorylation and oligomerization.
Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson’s disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies. |
---|---|
AbstractList | Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson's disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies. Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson's disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies.Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson's disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies. •α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in MPTP-treated monkeys.•α-Syn phosphorylation is accompanied by alterations in its regulatory enzymes PP2A and PLK2.•DAergic degeneration is synchronized in the brain and colon of MPTP-treated monkeys.•Altered PLK2 and PP2A activity contribute to α-syn phosphorylation and oligomerization. Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system (NSS) and enteric nervous system (ENS) of patients with Parkinson’s disease (PD). Whether these alterations in α-syn and DAergic neurons occur synchronously in the two nervous systems or follow a process that spreads from the gut to the brain remains a subject of debate. Here, in MPTP-intoxicated cynomolgus monkeys, we showed a parallel DAergic degeneration in the colon as well as in the substantia nigra and striatum (SN/STR), as indicated by reduced expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). In addition, we observed a simultaneous increase in the concentrations of total, phosphorylated, and oligomeric α-syn in the colon and SN/STR. Moreover, we identified that the above changes in α-syn were associated with an increase in the expression of polo-like kinase 2 (PLK2), an enzyme that promotes α-syn phosphorylation, and a decrease in the activity of protein phosphatase 2A (PP2A), an enzyme that facilitates α-syn dephosphorylation. Because the colonic ENS can be readily analyzed using routine biopsies, the shared pathological features between the colonic ENS and the brain NSS found in this study provide useful information for assessing and understanding the neuropathology in PD patients using colonic biopsies. |
ArticleNumber | 134640 |
Author | Yang, Weiwei Li, Jie Li, Xuran Chen, Min Liu, Chengwei Li, Xin Yu, Shun |
Author_xml | – sequence: 1 givenname: Xuran surname: Li fullname: Li, Xuran organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China – sequence: 2 givenname: Weiwei surname: Yang fullname: Yang, Weiwei organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China – sequence: 3 givenname: Xin surname: Li fullname: Li, Xin organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China – sequence: 4 givenname: Min surname: Chen fullname: Chen, Min organization: Laboratory of Neuroscience, Affiliated Hospital of Guilin Medical University, Guilin, China – sequence: 5 givenname: Chengwei surname: Liu fullname: Liu, Chengwei organization: Laboratory of Neuroscience, Affiliated Hospital of Guilin Medical University, Guilin, China – sequence: 6 givenname: Jie surname: Li fullname: Li, Jie organization: Department of Neurology, Beijing Daxing District Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China – sequence: 7 givenname: Shun surname: Yu fullname: Yu, Shun email: yushun103@163.com organization: Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31759083$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URKeFN0DISzYZ7NjODwukquJPKqKLsrac6zszniZ2sJ2K4S36xs2QwoIFrGzJ3zmSv3NGTnzwSMhLztac8erNfu1x6jGvS8bbNReykuwJWfGmLou6rcsTsmKCyUK0kp2Ss5T2jDHFlXxGTgWvVcsasSL3F_24M0U6-Al6dJ6G3m3DgNH9NNkFT4231IbRDM5j3DqgFrc4X5fXADBFOqdhF4MPU-oPdC7JO6RdNG6JQ-iP6IZ-ub65LpzP4YcDk9HS0cRb51Pwzng6BH-Lh_ScPN2YPuGLx_OcfPvw_ubyU3H19ePny4urAkRV5gK6qhRooTSsrQTvlAQmRcWNmT1YUQvWKrCmahSoToEQYNFg18AGgaFR4py8XnrHGL5PmLIeXALse-Nx_oguj5KaWkk5o68e0akb0OoxusHEg_6tcQbkAkAMKUXc_EE408e19F4va-njWnpZa469_SsGLv8Sm2d5_f_C75YwzpLuHEadwKEHtC4iZG2D-3fBA03JtxE |
CitedBy_id | crossref_primary_10_3389_fonc_2022_956225 crossref_primary_10_1152_jn_00106_2024 crossref_primary_10_34133_research_0183 crossref_primary_10_1080_15548627_2024_2448914 crossref_primary_10_2174_1874196702008010006 crossref_primary_10_3390_brainsci12060779 crossref_primary_10_3390_ijms23158586 crossref_primary_10_1016_j_ejphar_2022_175029 crossref_primary_10_3390_molecules27217414 crossref_primary_10_3390_biomedicines12081634 crossref_primary_10_3389_fnagi_2024_1437622 crossref_primary_10_1016_j_neurobiolaging_2023_05_007 crossref_primary_10_1007_s11427_020_1756_9 crossref_primary_10_1038_s41531_020_00150_x crossref_primary_10_3390_biomedicines9030272 crossref_primary_10_1016_j_brainresbull_2021_09_009 crossref_primary_10_3389_fnagi_2022_899892 crossref_primary_10_1007_s00259_024_06638_5 crossref_primary_10_1016_j_brainres_2021_147609 |
Cites_doi | 10.1016/j.neuroscience.2014.12.003 10.3390/ijerph13090881 10.3233/JPD-160779 10.1016/j.bbadis.2008.11.007 10.1016/j.parkreldis.2018.08.010 10.3389/fnana.2014.00083 10.1016/j.nbd.2005.05.028 10.1016/j.neulet.2005.11.012 10.1016/j.expneurol.2008.01.004 10.1002/mds.26480 10.1002/cmdc.201300166 10.1016/j.neuint.2019.03.013 10.1016/j.nbd.2018.01.008 10.5056/jnm17141 10.1073/pnas.0904229106 10.1016/S0306-4522(03)00036-8 10.1016/j.tins.2016.10.008 10.1016/0006-8993(84)90777-7 10.1016/j.neulet.2017.10.047 10.1096/fj.03-1449com 10.1016/j.neuroscience.2018.03.026 10.1016/j.neuroscience.2012.01.028 10.1016/j.pharmthera.2019.02.011 10.1093/jnen/nly024 10.1016/0006-8993(90)91788-I 10.1016/j.neuron.2019.05.035 10.1007/s00415-012-6801-2 10.1093/ilar/ilx021 10.1016/j.neurobiolaging.2015.06.004 10.1016/S0140-6736(14)61393-3 10.1038/cddis.2014.175 10.1016/j.neuroscience.2006.12.028 10.1007/s12264-016-0069-y 10.3233/JAD-2001-3608 10.3389/fnins.2019.00382 10.1097/00001756-200001170-00041 10.18632/oncotarget.6445 10.3390/ijms18020469 10.1016/j.jns.2014.03.028 |
ContentType | Journal Article |
Copyright | 2019 Elsevier B.V. Copyright © 2019 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2019 Elsevier B.V. – notice: Copyright © 2019 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.neulet.2019.134640 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1872-7972 |
ExternalDocumentID | 31759083 10_1016_j_neulet_2019_134640 S0304394019307438 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAXLA AAXUO ABCQJ ABFNM ABFRF ABJNI ABLJU ABMAC ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSN SSZ T5K WH7 YCJ ~G- .55 .GJ 29N 5VS AAEDT AAQFI AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ABXDB ACRPL ACVFH ADCNI ADIYS ADMUD ADNMO AEIPS AETEA AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION FEDTE FGOYB G-2 HMQ HVGLF HZ~ MVM R2- SEW SNS SSH WUQ X7M ZGI ZXP ZY4 CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c362t-cb623edc2a09631b54c04361aa640d373095cda685c5b5c33cdeaeb8cfec0ea53 |
IEDL.DBID | .~1 |
ISSN | 0304-3940 1872-7972 |
IngestDate | Fri Jul 11 00:38:55 EDT 2025 Thu Apr 03 07:05:22 EDT 2025 Thu Apr 24 23:00:59 EDT 2025 Tue Jul 01 01:44:00 EDT 2025 Fri Feb 23 02:47:59 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | DAergic Substantia nigra CNS ENS MPP STR m-α Dopaminergic neurons p-α-syn SD Striatum PNS SN Colon α-synuclein PBS t-α-syn EGCG PLK2 PP2A PVDF NSS LNs SDS-PAGE PD TH α-syn o-α-syn DAT MPTP LBs Parkinson’s disease ELISA |
Language | English |
License | Copyright © 2019 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c362t-cb623edc2a09631b54c04361aa640d373095cda685c5b5c33cdeaeb8cfec0ea53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 31759083 |
PQID | 2317587544 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2317587544 pubmed_primary_31759083 crossref_primary_10_1016_j_neulet_2019_134640 crossref_citationtrail_10_1016_j_neulet_2019_134640 elsevier_sciencedirect_doi_10_1016_j_neulet_2019_134640 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-01-18 |
PublicationDateYYYYMMDD | 2020-01-18 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-18 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Neuroscience letters |
PublicationTitleAlternate | Neurosci Lett |
PublicationYear | 2020 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Yue, Zeng, Tang, Tao, Chan (bib0065) 2017; 33 Goetze, Woitalla (bib0180) 2008; 210 Huang, Wu, Wang, Ge, Rizak, Wu, Li, Xu, Lv, Yin, Hu, Li (bib0055) 2018; 379 Liu, Chen, Mi, Yang, Li, Wang, Yin, Li, Yue, Chan, Yu (bib0090) 2015; 36 Wu, Lou, Alerte, Stachowski, Chen, Singleton, Hamilton, Perez (bib0100) 2012; 207 Ruffmann, Parkkinen (bib0115) 2016; 31 Scudamore, Ciossek (bib0130) 2018; 77 Dong, Qin, Huang, Ji, Wu (bib0160) 2019; 126 Engelender, Isacson (bib0185) 2017; 40 Bourdenx, Bezard, Dehay (bib0135) 2014; 8 Chen, Wang, Yue, Li, Wang, Li, Chan, Yu (bib0165) 2015; 286 Manfredsson, Luk, Benskey, Gezer, Garcia, Kuhn, Sandoval, Patterson, O’Mara, Yonkers, Kordower (bib0175) 2018; 112 Cersosimo, Raina, Pecci, Pellene, Calandra, Gutierrez, Micheli, Benarroch (bib0010) 2013; 260 Hinkle, Perepezko, Mills, Mari, Butala, Dawson, Pantelyat, Rosenthal, Pontone (bib0105) 2018; 55 Kim, Kwon, Kam, Panicker, Karuppagounder, Lee, Lee, Kim, Kook, Foss, Shen, Lee, Kulkarni, Pasricha, Lee, Pomper, Dawson, Dawson, Ko (bib0170) 2019; 103 Oueslati (bib0020) 2016; 6 Emborg (bib0030) 2017; 58 Canerina-Amaro, Pereda, Diaz, Rodriguez-Barreto, Casanas-Sanchez, Heffer, Garcia-Esparcia, Ferrer, Puertas-Avendano, Marin (bib0060) 2019; 13 Kalia, Lang (bib0005) 2015; 386 Yu, Li, Liu, Han, Zhang, Li, Xu, Liu, Gao, Yang, Ueda, Chan (bib0085) 2007; 145 Hossain, Alim, Takeda, Kaji, Shinoda, Ueda (bib0070) 2001; 3 Perez-Revuelta, Hettich, Ciociaro, Rotermund, Kahle, Krauss, Di Monte (bib0145) 2014; 5 Kozina, Khakimova, Khaindrava, Kucheryanu, Vorobyeva, Krasnov, Georgieva, Kerkerian-Le Goff, Ugrumov (bib0110) 2014; 340 Lee, Jung, Chung, Hong, Kim, Lee, Hwang, Ryu, Kim, Lee, Seo, Park, Yang, Ye, Byeon, Choe, Jung, Yang, Myung (bib0015) 2018; 24 Chen, Yang, Li, Li, Wang, Yue, Yang, Chan, Yu (bib0095) 2016; 7 El-Agnaf, Salem, Paleologou, Curran, Gibson, Court, Schlossmacher, Allsop (bib0080) 2006; 20 Riachi, Dietrich, Harik (bib0120) 1990; 533 Elgenaidi, Spiers (bib0155) 2019; 198 Purisai, McCormack, Langston, Johnston, Di Monte (bib0035) 2005; 20 Kowall, Hantraye, Brouillet, Beal, McKee, Ferrante (bib0040) 2000; 11 Valdinocci, Radford, Siow, Chung, Pountney (bib0195) 2017; 18 Langston, Forno, Rebert, Irwin (bib0045) 1984; 292 Nandipati, Litvan (bib0190) 2016; 13 Braak, de Vos, Bohl, Del Tredici (bib0025) 2006; 396 Li, Yang, Li, Chen, Liu, Yu (bib0075) 2018; 662 Matsumoto, Wang, Ma, Sung, Matoba, Hwang (bib0150) 2009; 106 Schluter, Fornai, Alessandri, Takamori, Geppert, Jahn, Sudhof (bib0125) 2003; 118 Banerjee, Starkov, Beal, Thomas (bib0050) 2009; 1792 Aubele, Hom, Adler, Galemmo, Bowers, Truong, Pan, Beroza, Neitz, Yao, Lin, Tonn, Zhang, Bova, Ren, Tam, Ruslim, Baker, Diep, Fitzgerald, Hoffman, Motter, Fauss, Tanaka, Dappen, Jagodzinski, Chan, Konradi, Latimer, Zhu, Sham, Anderson, Bergeron, Artis (bib0140) 2013; 8 Chen (10.1016/j.neulet.2019.134640_bib0165) 2015; 286 Oueslati (10.1016/j.neulet.2019.134640_bib0020) 2016; 6 Kim (10.1016/j.neulet.2019.134640_bib0170) 2019; 103 Wu (10.1016/j.neulet.2019.134640_bib0100) 2012; 207 Bourdenx (10.1016/j.neulet.2019.134640_bib0135) 2014; 8 Schluter (10.1016/j.neulet.2019.134640_bib0125) 2003; 118 Aubele (10.1016/j.neulet.2019.134640_bib0140) 2013; 8 Engelender (10.1016/j.neulet.2019.134640_bib0185) 2017; 40 Emborg (10.1016/j.neulet.2019.134640_bib0030) 2017; 58 Canerina-Amaro (10.1016/j.neulet.2019.134640_bib0060) 2019; 13 Riachi (10.1016/j.neulet.2019.134640_bib0120) 1990; 533 Manfredsson (10.1016/j.neulet.2019.134640_bib0175) 2018; 112 Perez-Revuelta (10.1016/j.neulet.2019.134640_bib0145) 2014; 5 Valdinocci (10.1016/j.neulet.2019.134640_bib0195) 2017; 18 Braak (10.1016/j.neulet.2019.134640_bib0025) 2006; 396 Kowall (10.1016/j.neulet.2019.134640_bib0040) 2000; 11 Huang (10.1016/j.neulet.2019.134640_bib0055) 2018; 379 Yu (10.1016/j.neulet.2019.134640_bib0085) 2007; 145 Scudamore (10.1016/j.neulet.2019.134640_bib0130) 2018; 77 El-Agnaf (10.1016/j.neulet.2019.134640_bib0080) 2006; 20 Lee (10.1016/j.neulet.2019.134640_bib0015) 2018; 24 Matsumoto (10.1016/j.neulet.2019.134640_bib0150) 2009; 106 Hinkle (10.1016/j.neulet.2019.134640_bib0105) 2018; 55 Langston (10.1016/j.neulet.2019.134640_bib0045) 1984; 292 Ruffmann (10.1016/j.neulet.2019.134640_bib0115) 2016; 31 Hossain (10.1016/j.neulet.2019.134640_bib0070) 2001; 3 Dong (10.1016/j.neulet.2019.134640_bib0160) 2019; 126 Li (10.1016/j.neulet.2019.134640_bib0075) 2018; 662 Purisai (10.1016/j.neulet.2019.134640_bib0035) 2005; 20 Chen (10.1016/j.neulet.2019.134640_bib0095) 2016; 7 Yue (10.1016/j.neulet.2019.134640_bib0065) 2017; 33 Elgenaidi (10.1016/j.neulet.2019.134640_bib0155) 2019; 198 Nandipati (10.1016/j.neulet.2019.134640_bib0190) 2016; 13 Liu (10.1016/j.neulet.2019.134640_bib0090) 2015; 36 Kozina (10.1016/j.neulet.2019.134640_bib0110) 2014; 340 Kalia (10.1016/j.neulet.2019.134640_bib0005) 2015; 386 Cersosimo (10.1016/j.neulet.2019.134640_bib0010) 2013; 260 Banerjee (10.1016/j.neulet.2019.134640_bib0050) 2009; 1792 Goetze (10.1016/j.neulet.2019.134640_bib0180) 2008; 210 |
References_xml | – volume: 33 start-page: 17 year: 2017 end-page: 27 ident: bib0065 article-title: MPTP induces systemic parkinsonism in middle-aged cynomolgus monkeys: clinical evolution and outcomes publication-title: Neurosci. Bull. – volume: 103 start-page: 627 year: 2019 end-page: 641 ident: bib0170 article-title: Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson’s disease publication-title: Neuron – volume: 8 start-page: 1295 year: 2013 end-page: 1313 ident: bib0140 article-title: Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain publication-title: ChemMedChem – volume: 18 year: 2017 ident: bib0195 article-title: Potential modes of intercellular alpha-synuclein transmission publication-title: Int. J. Mol. Sci. – volume: 126 start-page: 178 year: 2019 end-page: 186 ident: bib0160 article-title: Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson’s disease publication-title: Neurochem. Int. – volume: 6 start-page: 39 year: 2016 end-page: 51 ident: bib0020 article-title: Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? publication-title: J. Parkinsons Dis. – volume: 20 start-page: 419 year: 2006 end-page: 425 ident: bib0080 article-title: Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease publication-title: FASEB J. – volume: 379 start-page: 302 year: 2018 end-page: 315 ident: bib0055 article-title: Phosphorylated alpha-synuclein accumulations and Lewy body-like pathology distributed in Parkinson’s disease-related brain areas of aged Rhesus monkeys treated with MPTP publication-title: Neuroscience – volume: 118 start-page: 985 year: 2003 end-page: 1002 ident: bib0125 article-title: Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice publication-title: Neuroscience – volume: 7 start-page: 8466 year: 2016 end-page: 8480 ident: bib0095 article-title: Age- and brain region-dependent alpha-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating alpha-synuclein phosphorylation in aging monkey brains publication-title: Oncotarget – volume: 8 start-page: 83 year: 2014 ident: bib0135 article-title: Lysosomes and alpha-synuclein form a dangerous duet leading to neuronal cell death publication-title: Front. Neuroanat. – volume: 210 start-page: 281 year: 2008 end-page: 285 ident: bib0180 article-title: The role of MPTP in Parkinson’s disease: connecting brain and gut? publication-title: Exp. Neurol. – volume: 386 start-page: 896 year: 2015 end-page: 912 ident: bib0005 article-title: Parkinson’s disease publication-title: Lancet – volume: 58 start-page: 190 year: 2017 end-page: 201 ident: bib0030 article-title: Nonhuman primate models of neurodegenerative disorders publication-title: ILAR J. – volume: 40 start-page: 4 year: 2017 end-page: 14 ident: bib0185 article-title: The threshold theory for Parkinson’s disease publication-title: Trends Neurosci. – volume: 198 start-page: 68 year: 2019 end-page: 89 ident: bib0155 article-title: Regulation of the phosphoprotein phosphatase 2A system and its modulation during oxidative stress: a potential therapeutic target publication-title: Pharmacol. Ther. – volume: 13 start-page: 382 year: 2019 ident: bib0060 article-title: Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with parkinson disease publication-title: Front. Neurosci. – volume: 106 start-page: 14542 year: 2009 end-page: 14546 ident: bib0150 article-title: Polo-like kinases mediate cell survival in mitochondrial dysfunction publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 11 start-page: 211 year: 2000 end-page: 213 ident: bib0040 article-title: MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons publication-title: Neuroreport – volume: 533 start-page: 6 year: 1990 end-page: 14 ident: bib0120 article-title: Effects of internal carotid administration of MPTP on rat brain and blood-brain barrier publication-title: Brain Res. – volume: 292 start-page: 390 year: 1984 end-page: 394 ident: bib0045 article-title: Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey publication-title: Brain Res. – volume: 31 start-page: 193 year: 2016 end-page: 202 ident: bib0115 article-title: Gut feelings about alpha-synuclein in gastrointestinal biopsies: biomarker in the making? publication-title: Mov. Disord. – volume: 5 start-page: e1209 year: 2014 ident: bib0145 article-title: Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation publication-title: Cell Death Dis. – volume: 396 start-page: 67 year: 2006 end-page: 72 ident: bib0025 article-title: Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology publication-title: Neurosci. Lett. – volume: 112 start-page: 106 year: 2018 end-page: 118 ident: bib0175 article-title: Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology publication-title: Neurobiol. Dis. – volume: 145 start-page: 539 year: 2007 end-page: 555 ident: bib0085 article-title: Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody publication-title: Neuroscience – volume: 55 start-page: 8 year: 2018 end-page: 14 ident: bib0105 article-title: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease publication-title: Parkinsonism Relat. Disord. – volume: 24 start-page: 469 year: 2018 end-page: 478 ident: bib0015 article-title: Relation of enteric alpha-synuclein to gastrointestinal dysfunction in patients with Parkinson’s disease and in neurologically intact subjects publication-title: J. Neurogastroenterol. Motil. – volume: 207 start-page: 288 year: 2012 end-page: 297 ident: bib0100 article-title: Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo publication-title: Neuroscience – volume: 77 start-page: 443 year: 2018 end-page: 453 ident: bib0130 article-title: Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo publication-title: J. Neuropathol. Exp. Neurol. – volume: 662 start-page: 276 year: 2018 end-page: 282 ident: bib0075 article-title: Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys publication-title: Neurosci. Lett. – volume: 36 start-page: 2649 year: 2015 end-page: 2659 ident: bib0090 article-title: Increased oligomerization and phosphorylation of alpha-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains publication-title: Neurobiol. Aging – volume: 340 start-page: 198 year: 2014 end-page: 207 ident: bib0110 article-title: Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism publication-title: J. Neurol. Sci. – volume: 260 start-page: 1332 year: 2013 end-page: 1338 ident: bib0010 article-title: Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms publication-title: J. Neurol. – volume: 20 start-page: 898 year: 2005 end-page: 906 ident: bib0035 article-title: Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates publication-title: Neurobiol. Dis. – volume: 3 start-page: 577 year: 2001 end-page: 584 ident: bib0070 article-title: Limited proteolysis of NACP/alpha-synuclein publication-title: J. Alzheimers Dis. – volume: 1792 start-page: 651 year: 2009 end-page: 663 ident: bib0050 article-title: Mitochondrial dysfunction in the limelight of Parkinson’s disease pathogenesis publication-title: Biochim. Biophys. Acta – volume: 286 start-page: 383 year: 2015 end-page: 392 ident: bib0165 article-title: Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral alpha-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys publication-title: Neuroscience – volume: 13 year: 2016 ident: bib0190 article-title: Environmental exposures and Parkinson’s disease publication-title: Int. J. Environ. Res. Public Health – volume: 286 start-page: 383 year: 2015 ident: 10.1016/j.neulet.2019.134640_bib0165 article-title: Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral alpha-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.12.003 – volume: 13 year: 2016 ident: 10.1016/j.neulet.2019.134640_bib0190 article-title: Environmental exposures and Parkinson’s disease publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph13090881 – volume: 6 start-page: 39 year: 2016 ident: 10.1016/j.neulet.2019.134640_bib0020 article-title: Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? publication-title: J. Parkinsons Dis. doi: 10.3233/JPD-160779 – volume: 1792 start-page: 651 year: 2009 ident: 10.1016/j.neulet.2019.134640_bib0050 article-title: Mitochondrial dysfunction in the limelight of Parkinson’s disease pathogenesis publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2008.11.007 – volume: 55 start-page: 8 year: 2018 ident: 10.1016/j.neulet.2019.134640_bib0105 article-title: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2018.08.010 – volume: 8 start-page: 83 year: 2014 ident: 10.1016/j.neulet.2019.134640_bib0135 article-title: Lysosomes and alpha-synuclein form a dangerous duet leading to neuronal cell death publication-title: Front. Neuroanat. doi: 10.3389/fnana.2014.00083 – volume: 20 start-page: 898 year: 2005 ident: 10.1016/j.neulet.2019.134640_bib0035 article-title: Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2005.05.028 – volume: 396 start-page: 67 year: 2006 ident: 10.1016/j.neulet.2019.134640_bib0025 article-title: Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2005.11.012 – volume: 210 start-page: 281 year: 2008 ident: 10.1016/j.neulet.2019.134640_bib0180 article-title: The role of MPTP in Parkinson’s disease: connecting brain and gut? publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2008.01.004 – volume: 31 start-page: 193 year: 2016 ident: 10.1016/j.neulet.2019.134640_bib0115 article-title: Gut feelings about alpha-synuclein in gastrointestinal biopsies: biomarker in the making? publication-title: Mov. Disord. doi: 10.1002/mds.26480 – volume: 8 start-page: 1295 year: 2013 ident: 10.1016/j.neulet.2019.134640_bib0140 article-title: Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain publication-title: ChemMedChem doi: 10.1002/cmdc.201300166 – volume: 126 start-page: 178 year: 2019 ident: 10.1016/j.neulet.2019.134640_bib0160 article-title: Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson’s disease publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2019.03.013 – volume: 112 start-page: 106 year: 2018 ident: 10.1016/j.neulet.2019.134640_bib0175 article-title: Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2018.01.008 – volume: 24 start-page: 469 year: 2018 ident: 10.1016/j.neulet.2019.134640_bib0015 article-title: Relation of enteric alpha-synuclein to gastrointestinal dysfunction in patients with Parkinson’s disease and in neurologically intact subjects publication-title: J. Neurogastroenterol. Motil. doi: 10.5056/jnm17141 – volume: 106 start-page: 14542 year: 2009 ident: 10.1016/j.neulet.2019.134640_bib0150 article-title: Polo-like kinases mediate cell survival in mitochondrial dysfunction publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0904229106 – volume: 118 start-page: 985 year: 2003 ident: 10.1016/j.neulet.2019.134640_bib0125 article-title: Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice publication-title: Neuroscience doi: 10.1016/S0306-4522(03)00036-8 – volume: 40 start-page: 4 year: 2017 ident: 10.1016/j.neulet.2019.134640_bib0185 article-title: The threshold theory for Parkinson’s disease publication-title: Trends Neurosci. doi: 10.1016/j.tins.2016.10.008 – volume: 292 start-page: 390 year: 1984 ident: 10.1016/j.neulet.2019.134640_bib0045 article-title: Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey publication-title: Brain Res. doi: 10.1016/0006-8993(84)90777-7 – volume: 662 start-page: 276 year: 2018 ident: 10.1016/j.neulet.2019.134640_bib0075 article-title: Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2017.10.047 – volume: 20 start-page: 419 year: 2006 ident: 10.1016/j.neulet.2019.134640_bib0080 article-title: Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease publication-title: FASEB J. doi: 10.1096/fj.03-1449com – volume: 379 start-page: 302 year: 2018 ident: 10.1016/j.neulet.2019.134640_bib0055 article-title: Phosphorylated alpha-synuclein accumulations and Lewy body-like pathology distributed in Parkinson’s disease-related brain areas of aged Rhesus monkeys treated with MPTP publication-title: Neuroscience doi: 10.1016/j.neuroscience.2018.03.026 – volume: 207 start-page: 288 year: 2012 ident: 10.1016/j.neulet.2019.134640_bib0100 article-title: Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo publication-title: Neuroscience doi: 10.1016/j.neuroscience.2012.01.028 – volume: 198 start-page: 68 year: 2019 ident: 10.1016/j.neulet.2019.134640_bib0155 article-title: Regulation of the phosphoprotein phosphatase 2A system and its modulation during oxidative stress: a potential therapeutic target publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2019.02.011 – volume: 77 start-page: 443 year: 2018 ident: 10.1016/j.neulet.2019.134640_bib0130 article-title: Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1093/jnen/nly024 – volume: 533 start-page: 6 year: 1990 ident: 10.1016/j.neulet.2019.134640_bib0120 article-title: Effects of internal carotid administration of MPTP on rat brain and blood-brain barrier publication-title: Brain Res. doi: 10.1016/0006-8993(90)91788-I – volume: 103 start-page: 627 year: 2019 ident: 10.1016/j.neulet.2019.134640_bib0170 article-title: Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson’s disease publication-title: Neuron doi: 10.1016/j.neuron.2019.05.035 – volume: 260 start-page: 1332 year: 2013 ident: 10.1016/j.neulet.2019.134640_bib0010 article-title: Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms publication-title: J. Neurol. doi: 10.1007/s00415-012-6801-2 – volume: 58 start-page: 190 year: 2017 ident: 10.1016/j.neulet.2019.134640_bib0030 article-title: Nonhuman primate models of neurodegenerative disorders publication-title: ILAR J. doi: 10.1093/ilar/ilx021 – volume: 36 start-page: 2649 year: 2015 ident: 10.1016/j.neulet.2019.134640_bib0090 article-title: Increased oligomerization and phosphorylation of alpha-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2015.06.004 – volume: 386 start-page: 896 year: 2015 ident: 10.1016/j.neulet.2019.134640_bib0005 article-title: Parkinson’s disease publication-title: Lancet doi: 10.1016/S0140-6736(14)61393-3 – volume: 5 start-page: e1209 year: 2014 ident: 10.1016/j.neulet.2019.134640_bib0145 article-title: Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation publication-title: Cell Death Dis. doi: 10.1038/cddis.2014.175 – volume: 145 start-page: 539 year: 2007 ident: 10.1016/j.neulet.2019.134640_bib0085 article-title: Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.12.028 – volume: 33 start-page: 17 year: 2017 ident: 10.1016/j.neulet.2019.134640_bib0065 article-title: MPTP induces systemic parkinsonism in middle-aged cynomolgus monkeys: clinical evolution and outcomes publication-title: Neurosci. Bull. doi: 10.1007/s12264-016-0069-y – volume: 3 start-page: 577 year: 2001 ident: 10.1016/j.neulet.2019.134640_bib0070 article-title: Limited proteolysis of NACP/alpha-synuclein publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-2001-3608 – volume: 13 start-page: 382 year: 2019 ident: 10.1016/j.neulet.2019.134640_bib0060 article-title: Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with parkinson disease publication-title: Front. Neurosci. doi: 10.3389/fnins.2019.00382 – volume: 11 start-page: 211 year: 2000 ident: 10.1016/j.neulet.2019.134640_bib0040 article-title: MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons publication-title: Neuroreport doi: 10.1097/00001756-200001170-00041 – volume: 7 start-page: 8466 year: 2016 ident: 10.1016/j.neulet.2019.134640_bib0095 article-title: Age- and brain region-dependent alpha-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating alpha-synuclein phosphorylation in aging monkey brains publication-title: Oncotarget doi: 10.18632/oncotarget.6445 – volume: 18 year: 2017 ident: 10.1016/j.neulet.2019.134640_bib0195 article-title: Potential modes of intercellular alpha-synuclein transmission publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18020469 – volume: 340 start-page: 198 year: 2014 ident: 10.1016/j.neulet.2019.134640_bib0110 article-title: Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2014.03.028 |
SSID | ssj0005154 |
Score | 2.407491 |
Snippet | •α-Syn oligomerization occurs in parallel in the brain and colon of MPTP-treated monkeys.•α-Syn oligomerization correlates with its phosphorylation in... Dopaminergic (DAergic) degeneration and abnormal α-synuclein (α-syn) expression, phosphorylation and aggregation are observed in both the nigrostriatal system... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 134640 |
SubjectTerms | alpha-Synuclein - metabolism Animals Brain - metabolism Brain - pathology Colon Dopaminergic neurons Dopaminergic Neurons - pathology Enteric Nervous System - metabolism Enteric Nervous System - pathology Macaca fascicularis Male Nerve Degeneration - metabolism Nerve Degeneration - pathology Parkinsonian Disorders - metabolism Parkinsonian Disorders - pathology Parkinson’s disease Striatum Substantia nigra α-synuclein |
Title | Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys |
URI | https://dx.doi.org/10.1016/j.neulet.2019.134640 https://www.ncbi.nlm.nih.gov/pubmed/31759083 https://www.proquest.com/docview/2317587544 |
Volume | 716 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBalg7GXsbX7kXUtGoy9qbFiy7UeQ2nJNlIKa6FvQjopxSOVQ5NA89L_of_x7mS7bLBR2Ksl2UJ3vvuku_vE2GcVqsxVKhMAWokCRlZY8KXQUNhMQ8ikpULh6Vk5uSy-XamrLXbc18JQWmVn-1ubnqx192TYreZwUdfDHxTUo3u9EYKQH6SC36I4Ii0_vP8tzUOqlkKKIgDYuy-fSzleMaxxdSjBSx_KvCjpCOTv7ulf8DO5odNX7GWHH_m4neJrthXiDtsdR9w732z4F54yOtNR-Q57Pu0C57vsYUw1tWK5icRfXEfezOvrhqI1bRkmt9Fzjxvom1QMWAP34ToxUqfWBmB9y3E0EJdus17ONxxfguCRO7pjIg0n_mvsOuPT84tzUcdVc5cK7DxfWDqRR2SPushR79FwLN-wy9OTi-OJ6G5jEIBObiXAIVIKHqWJu55cOlUA0ddLa3HZfI6WQivwtqwUKKcgz8EHG1wFswBZsCp_y7ZjE8N7xpUM5ayypdajgHDMukLPvNaB6ABl7uyA5b0QDHRU5XRjxtz0OWk_TSs6Q6IzregGTDyOWrRUHU_0P-rla_5QOYPe5ImRn3p1MPg3UojFxoCLb0YExyoiFRywd62ePM6FmjQi3g___d099mJE2_1MCll9ZNur23XYR0y0cgdJ6Q_Ys_HX75OzXyuED6E |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBddB9textbuI_vUYOxNjRVbnvUYykq2NaWwFPompJNSXFI5NAksL_sf9h_vTrbLBhuFvcaSY3Snu590d79j7L0KVeYqlQkArUQBIyss-FJoKGymIWTSUqHw9KScnBVfztX5Djvsa2EorbKz_a1NT9a6-2XYreZwWdfDbxTUo77eCEHID1Z32N0Cty-1MTj48Vueh1QthxSFAHB4Xz-Xkrxi2ODyUIaXPpB5UdIdyN_907_wZ_JDR4_Yww5A8nH7jY_ZToh7bH8c8fB8teUfeErpTHfle-zetIuc77OfYyqqFattJALjOvJmUV80FK5p6zC5jZ57PEFfpWrAGrgPF4mSOj1tADbXHGcDkek2m9Viy_EliB65oyYTaToRYOPQOZ-ezk5FHdfN91Rh5_nS0pU8QntURo6Kj5Zj9YSdHX2aHU5E145BAHq5tQCHUCl4FCcee3LpVAHEXy-txWXzOZoKrcDbslKgnII8Bx9scBXMA2TBqvwp241NDM8ZVzKU88qWWo8C4jHrCj33WgfiA5S5swOW90Iw0HGVU8uMhemT0i5NKzpDojOt6AZM3Mxatlwdt4z_2MvX_KFzBt3JLTPf9epgcDtSjMXGgItvRoTHKmIVHLBnrZ7cfAs90gh5X_z3_75l9yez6bE5_nzy9SV7MKKzfyaFrF6x3fX1JrxGgLR2b9IG-AU7nhEv |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alpha-synuclein+oligomerization+and+dopaminergic+degeneration+occur+synchronously+in+the+brain+and+colon+of+MPTP-intoxicated+parkinsonian+monkeys&rft.jtitle=Neuroscience+letters&rft.au=Li%2C+Xuran&rft.au=Yang%2C+Weiwei&rft.au=Li%2C+Xin&rft.au=Chen%2C+Min&rft.date=2020-01-18&rft.issn=1872-7972&rft.eissn=1872-7972&rft.volume=716&rft.spage=134640&rft_id=info:doi/10.1016%2Fj.neulet.2019.134640&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3940&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3940&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3940&client=summon |